Avantor expands China footprint with RIM Bio acquisition

2-Jun-2021

The manufacturer’s Changzhou, China facility will be Avantor's first single-use production plant in the AMEA region

Avantor, a provider of products and services to customers in the life sciences and advanced technologies & applied materials industries, has acquired RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

The manufacturer’s Changzhou, China facility will be Avantor's first single-use production plant in the AMEA region, building on its existing single-use manufacturing network in the Americas and Europe and greatly increasing capacity.

Dr Ger Brophy, Executive VP, Biopharma Production at Avantor, said: "Adding RIM Bio enables Avantor to better serve our customers by expanding our single-use manufacturing, distribution, and cleanroom capabilities to the AMEA region. RIM serves as an anchor for us to build our presence in this key region, as we better position Avantor to capture long-term opportunities in the growing, global bioproduction space."

Established in 2009, RIM Bio provides a range of single-use 2D bags, 3D bags, tank liners, bag assemblies and multi-bag manifolds used in the manufacturing of biologics including monoclonal antibodies (mAbs), vaccines, cell and gene therapies, and recombinant proteins.

Sign up for your free email newsletter

In December 2019, Avantor opened its Shanghai Innovation & Customer Support centre, a dedicated bioprocessing facility focused on research, application development and process optimisation services for biopharma companies across AMEA.

Companies